Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...
SandboxAQ, a startup drawing on quantum computing techniques to develop quantitative artificial intelligence models for ...
Google-Backed AI Drug Discovery Startup Raises $600 Million (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...